Table 4.

Kruskal–Wallis test comparing the means of lipid panel components between study population sub-groups.

	No causative mutation (N = 167)	LDLR (N = 97)	Apo B (N = 22)	PCSK9/Apo E (N = 3)	p-Value
Total cholesterol (mg/dl)	287 ± 42	297 ± 68	309 ± 55	289 ± 77	0.551
LDL-c (mg/dl)	203 ± 37	225 ± 61	231 ± 52	218 ± 51	0.014
HDL-c (mg/dl)	63 ± 30	55 ± 14	63 ± 15	64 ± 14	0.017
Lpa (mg/dl)	46 ± 52	42 ± 46	37 ± 38	36 ± 34	0.986
Apo A1 (mg/dl)	159 ± 23	149 ± 26	159 ± 26	174 ± 41	0.033
Apo B (mg/dl)	146 ± 29	153 ± 42	162 ± 30	194 ± 81	0.150

LDL-R, low-density lipoprotein cholesterol receptor; PCSK9, proprotein convertase subtilisin/kexin type-9; Apo, apolipoprotein; LDL-c, low-density lipoprotein cholesterol; HDL-c, high-density lipoprotein cholesterol; Lpa, lipoprotein a.